Johnson & Johnson (TSX:JNJ)
Canada · Delayed Price · Currency is CAD 33.97
+0.33 (0.98%)
Oct 26, 2026, 3:55 PM EDT
Johnson & Johnson Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
| 99,335 | 94,193 | 88,821 | 85,159 | 79,990 | 78,740 | |
Revenue Growth | 7.80% | 6.05% | 4.30% | 6.46% | 1.59% | -4.66% |
Cost of Revenue | 32,011 | 30,065 | 27,036 | 26,244 | 24,596 | 23,402 |
Gross Profit | 67,324 | 64,128 | 61,785 | 58,915 | 55,394 | 55,338 |
Selling, General & Admin | 24,829 | 23,130 | 21,952 | 20,166 | 19,078 | 19,506 |
Research & Development | 16,084 | 14,665 | 17,232 | 15,085 | 14,135 | 14,277 |
Operating Expenses | 40,913 | 37,795 | 39,184 | 35,251 | 33,213 | 33,783 |
Operating Income | 26,411 | 26,333 | 22,601 | 23,664 | 22,181 | 21,555 |
Interest Expense | -984 | -971 | -755 | -772 | -276 | -183 |
Interest & Investment Income | 871 | 1,056 | 1,332 | 1,261 | 490 | 53 |
Currency Exchange Gain (Loss) | -314 | -254 | -214 | -366 | -286 | -216 |
Other Non Operating Income (Expenses) | 112 | 851 | 1,382 | -17,936 | -556 | -550 |
EBT Excluding Unusual Items | 26,096 | 27,015 | 24,346 | 5,851 | 21,553 | 20,659 |
Merger & Restructuring Charges | -743 | -812 | -1,469 | -798 | -575 | -209 |
Gain (Loss) on Sale of Investments | 481 | 400 | -300 | - | - | - |
Gain (Loss) on Sale of Assets | 263 | 263 | 226 | 117 | 380 | 617 |
Asset Writedown | -204 | -204 | -405 | -1,295 | -1,216 | -989 |
Legal Settlements | -7,000 | 6,000 | -5,500 | 11,500 | - | - |
Pretax Income | 17,737 | 32,581 | 16,687 | 15,062 | 19,359 | 19,178 |
Income Tax Expense | 1,642 | 5,777 | 2,621 | 1,736 | 2,989 | 1,377 |
Earnings From Continuing Operations | 16,095 | 26,804 | 14,066 | 13,326 | 16,370 | 17,801 |
Earnings From Discontinued Operations | - | - | - | 21,827 | 1,571 | 3,077 |
Net Income | 16,095 | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 |
Net Income to Common | 16,095 | 26,804 | 14,066 | 35,153 | 17,941 | 20,878 |
Net Income Growth | -35.93% | 90.56% | -59.99% | 95.94% | -14.07% | 41.89% |
Shares Outstanding (Basic) | 2,408 | 2,407 | 2,407 | 2,534 | 2,625 | 2,632 |
Shares Outstanding (Diluted) | 2,445 | 2,429 | 2,429 | 2,560 | 2,664 | 2,674 |
Shares Change | 0.80% | - | -5.12% | -3.89% | -0.38% | 0.12% |
EPS (Basic) | 6.68 | 11.13 | 5.84 | 13.88 | 6.83 | 7.93 |
EPS (Diluted) | 6.58 | 11.03 | 5.79 | 13.72 | 6.73 | 7.81 |
EPS Growth | -36.37% | 90.50% | -57.81% | 103.94% | -13.84% | 41.75% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Free Cash Flow | 20,590 | 19,698 | 19,842 | 18,410 | 17,488 | 19,758 |
Free Cash Flow Per Share | 8.42 | 8.11 | 8.17 | 7.19 | 6.57 | 7.39 |
Dividend Per Share | 5.280 | 5.140 | 4.910 | 4.700 | 4.450 | 4.190 |
Dividend Growth | 3.94% | 4.68% | 4.47% | 5.62% | 6.21% | 5.28% |
Gross Margin | 67.77% | 68.08% | 69.56% | 69.18% | 69.25% | 70.28% |
Operating Margin | 26.59% | 27.96% | 25.45% | 27.79% | 27.73% | 27.38% |
Profit Margin | 16.20% | 28.46% | 15.84% | 41.28% | 22.43% | 26.52% |
Free Cash Flow Margin | 20.73% | 20.91% | 22.34% | 21.62% | 21.86% | 25.09% |
EBITDA | 34,502 | 33,836 | 29,940 | 30,767 | 28,510 | 28,206 |
EBITDA Margin | 34.73% | 35.92% | 33.71% | 36.13% | 35.64% | 35.82% |
D&A For EBITDA | 8,091 | 7,503 | 7,339 | 7,103 | 6,329 | 6,651 |
EBIT | 26,411 | 26,333 | 22,601 | 23,664 | 22,181 | 21,555 |
EBIT Margin | 26.59% | 27.96% | 25.45% | 27.79% | 27.73% | 27.38% |
Effective Tax Rate | 9.26% | 17.73% | 15.71% | 11.53% | 15.44% | 7.18% |
Advertising Expenses | - | 1,600 | 600 | 500 | 700 | 1,200 |